K
KeepMED
Developing disruptive solutions for the treatment of Obstructive Sleep Apnea (OSA)
About KeepMED
Keepap.com operates in the medical device industry, focusing on innovative solutions for Obstructive Sleep Apnea (OSA). The company's flagship product is a wearable, hoseless Positive Airway Pressure (PAP) device integrated into lightweight headgear, designed to provide therapeutic PAP on demand with minimal airflow. This product aims to improve the health and quality of life for individuals suffering from OSA by offering complete freedom of movement and enhanced mobility.
The primary clients are individuals diagnosed with Obstructive Sleep Apnea, a condition characterized by repeated episodes of partial or complete obstruction of the upper airway during sleep. The market for this product includes healthcare providers, sleep clinics, and direct-to-consumer sales channels.
Keepap.com operates on a business model that includes direct sales, partnerships with healthcare providers, and potential subscription services for ongoing product updates and support. Revenue is generated through the sale of the wearable PAP devices and possibly through ancillary services such as maintenance and customer support.
The company is led by Alex Rapoport, a serial entrepreneur with extensive experience in the medical device industry, and Nir Weiss, who has a strong background in multidisciplinary product and system development. The leadership team brings a wealth of expertise in medical technology and product innovation.
Source: Dealroom company dataAt a glance
- Status
- Closed
- Founded
- 2012
- Headquarters
- Rishon LeTsiyon, Israel
- Employees
- 5
- Open positions
- None listed
- Dealroom signal
- 0.0/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Accounting, Apnea, Respiratory, Non-Invasive medical devices and treatments
- Technology
- Artificial Intelligence, Hardware, Deep Tech, Computer Vision, Connected Device
- Business model
- Manufacturing
- Client focus
- b2b, b2c
- Links
- Website
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES C✓Equity / VC | Sep 2020 | $15M | $60M | Financiere Arbevel · Lavorel Medicare · 4See Ventures · C4 Ventures | — |
| SERIES B✓Equity / VC | Apr 2015 | $10M | $40M | Mérieux Equity Partners · C4 Ventures · Xenia Venture Capital · Pitango Venture Capital | — |
Growth signals
Latest recorded traffic for KeepMED is 270 monthly website visits, up 125% over the last three months. KeepMED's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A4 investors entered at this stage
Xenia Venture Capital
Mérieux Equity Partners
Pitango Venture Capital
C4 Ventures
Series B and later4 investors entered at this stage
- FAFinanciere Arbevel
Lavorel Medicare- 4V4See Ventures
Celeste Management
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about KeepMED on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See KeepMED’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.